Literature DB >> 2792736

Effects of tetracyclines on the production of extracellular proteins by members of the propionibacteriaceae.

I Chopra1, K Hacker.   

Abstract

The effect of tetracyclines on the synthesis of proteins in Propionibacterium avidum and P. acnes was examined. Synthesis of an extracellular lipase by P. avidum was slightly more sensitive to inhibition by tetracycline than total (cellular and extracellular) protein synthesis. The effect of tetracycline and other analogues on the synthesis of secreted proteins was also examined in P. avidum and P. acnes by protein radiolabelling experiments. In all cases the synthesis of secreted proteins was only about 2-fold more sensitive to inhibition by tetracyclines than total protein synthesis. These results contrast with previously published findings in Escherichia coli which show that synthesis of secreted proteins is highly susceptible to inhibition by tetracycline. The implications of these findings in relation to inhibition of membrane bound ribosomes by tetracyclines are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2792736     DOI: 10.1016/0378-1097(89)90070-0

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

1.  Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes.

Authors:  B Oliva; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

2.  Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy.

Authors:  Linda Ejim; Maya A Farha; Shannon B Falconer; Jan Wildenhain; Brian K Coombes; Mike Tyers; Eric D Brown; Gerard D Wright
Journal:  Nat Chem Biol       Date:  2011-04-24       Impact factor: 15.040

Review 3.  Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum, an Underrecognized Microorganism.

Authors:  Stéphane Corvec
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.